Globus Medical, Inc. rose 6.90% in premarket trading, with the company reaffirming its earnings guidance for the quarter. The company reported that its Q2 sales and adjusted EPS exceeded expectations, which is likely driving the positive market sentiment.
Comments
No comments yet